Relates to health insurance coverage for in vitro fertilization.
Summary
S03155 amends New York’s insurance law to expand and clarify health insurance coverage rules for in vitro fertilization (IVF). The bill adds a specific prohibition on insurers and health maintenance corporations requiring a woman age 35 or older to transfer all embryos from a prior IVF cycle before coverage will be provided for a subsequent cycle. In effect, it prevents a particular coverage condition that can delay or limit access to additional IVF treatment for older patients.
The bill leaves in place existing anti-discrimination language in the insurance law that bars coverage decisions based on factors such as expected length of life, disability, medical dependency, perceived quality of life, age, sex, sexual orientation, marital status, or gender identity. It applies to both the insurance law provisions governing certain group policies and the parallel provisions governing health service corporations, and it takes effect immediately upon enactment.
Impact
The bill would amend sections 3221 and 4303 of the Insurance Law, which govern health insurance and corporation coverage requirements, by adding a new IVF-specific coverage rule. Insurers and health plans subject to these provisions would no longer be able to condition coverage for a later IVF cycle on the transfer of all embryos from a prior cycle for patients age 35 and older. The practical effect is to broaden access to repeat IVF treatment and limit insurer discretion to impose this prerequisite, while reinforcing existing nondiscrimination standards in fertility coverage.
Sentiment
The voting history suggests broad support for the bill, with strong majority approval in Senate committee and on the Senate floor in both recorded votes. The available record shows no committee transcript debate, but the lopsided vote margins indicate that the measure was generally viewed favorably and as a targeted consumer and reproductive-health insurance reform. The bill’s framing as an IVF coverage measure likely contributed to the positive reception.
Contention
The main point of contention appears to be the specific prohibition on requiring transfer of all embryos from a prior cycle before covering another cycle for women age 35 and older. Supporters would likely view this as removing an unnecessary barrier to medically appropriate fertility care, while potential opponents may argue it limits insurer utilization controls or alters treatment protocols through insurance regulation. Because the bill is narrowly tailored to a defined age group and a specific coverage condition, any disagreement seems focused on the scope of mandated fertility coverage rather than on the broader nondiscrimination provisions.